Investigation of whether metformin can be used safely and effectively in patients with type 2 diabetes on haemodialysis

Phase 2

Recruiting

• Conditions: Type 2 Diabetes; Chronic Renal failure on haemodialysis; Metabolic and Endocrine - Diabetes; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12612000352808
• Lead Sponsor: Dr Tilenka Thynne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-03-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 6

Inclusion Criteria

> 18 years
Type 2 Diabetes
Receiving haemodialysis 3 times a week for greater than 3 months
Patients in which metformin would normally be used if they had normal renal function.
Consent

Exclusion Criteria

(1)Any patients in whom metformin would not be used in the setting of normal renal function including: Moderate to severe heart failure, liver failure, alcohol abuse, major psychiatric disorder, acutely unwell or otherwise medically unstable.
(2)Unable or unwilling to self monitor and record blood glucose levels via glucometer readings.
(3)Inability to provide written informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified